Risk stratification in middle-aged patients with congestive heart failure:prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model
C. Zugck et al., Risk stratification in middle-aged patients with congestive heart failure:prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model, EUR J HE FA, 3(5), 2001, pp. 577-585
Aims. The performance of a US-American scoring system (Heart Failure Surviv
al Score, HFSS) was prospectively evaluated in a sample of ambulatory patie
nts with congestive heart failure (CHF). Additionally, it was investigated
whether the HFSS might be simplified by assessment of the distance ambulate
d during a 6-min walk test (6'WT) instead of determination of peak oxygen u
ptake (peak Vo(2)). Methods and Results: In 208 middle-aged CHF patients (a
ge 54 +/- 10 years, 82% male, NYHA class 2.3 +/- 0.7; follow-up 28 +/- 14 m
onths) the seven variables of the HFSS: CHF aetiology; heart rate; mean art
erial pressure; serum sodium concentration; intraventricular conduction tim
e; left ventricular ejection fraction (LVEF); and peak Vo(2), were determin
ed. Additionally, a 6'WT was performed. The HFSS allowed discrimination bet
ween patients at low, medium and high risk, with mortality rates of 16, 39
and 50%, respectively. However, the prognostic power of the HFSS was not su
perior to a two-variable model consisting only of LVEF and peak Vo(2). The
areas under the receiver operating curves (AUC) for prediction of 1-year su
rvival were even higher for the two-variable model (0.84 vs. 0.74, P < 0.05
). Replacing peak Vo(2), with 6'WT resulted in a similar AUC (0.83). Conclu
sion: The HFSS continued to predict survival when applied to this patient s
ample. However, the HFSS was inferior to a two-variable model containing on
ly LVEF and either peak Vo(2). or 6'WT. As the 6'WT requires no sophisticat
ed equipment, a simplified two-variable model containing only LVEF and 6'WT
may be more widely applicable, and is therefore recommended. (C) 2001 Euro
pean Society of Cardiology. All rights reserved.